{"id":218447,"date":"2017-06-10T11:33:15","date_gmt":"2017-06-10T15:33:15","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/nanotech-based-test-can-predict-prostate-cancer-risk-better-business-standard.php"},"modified":"2017-06-10T11:33:15","modified_gmt":"2017-06-10T15:33:15","slug":"nanotech-based-test-can-predict-prostate-cancer-risk-better-business-standard","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanotech\/nanotech-based-test-can-predict-prostate-cancer-risk-better-business-standard.php","title":{"rendered":"Nanotech-based test can predict prostate cancer risk better &#8230; &#8211; Business Standard"},"content":{"rendered":"<p><\/p><p>      IANS |      Toronto June 10, 2017 Last Updated at 15:42 IST    <\/p><p>    Using nanotechnology, scientists have    developed a new diagnostic process that can identify aggressive    prostate cancer    from a single drop of blood with 40 per cent more accuracy than    current screening methods.  <\/p><p>    The Extracellular Vesicle Fingerprint    Predictive Score (EV-FPS) test uses machine learning to combine    information from millions of cancer    cell nano-particles in the blood to recognise the unique    fingerprint of aggressive prostate cancer.  <\/p><p>    The diagnostic, evaluated in a group of    men suspected of prostate cancer, correctly identified    aggressive prostate cancer 40    per cent more accurately than the most common blood test --    Prostate-Specific Antigen (PSA) and helped them avoid    unnecessary painful biopsies and over-treatment.  <\/p><p>    \"Higher sensitivity means that our test    will miss fewer aggressive cancers...for this kind of test you    want the sensitivity to be as high as possible because you    don't want to miss a single cancer    that should be treated,\" said John Lewis from the University of    Alberta in Canada.  <\/p><p>    Current tests such as the PSA and    digital rectal exam (DRE) often lead to unneeded biopsies, the    researchers said, while presenting the paper at the    International Society for Extracellular Vesicles conference in    Toronto recently.  <\/p><p>    More than 50 per cent of men who    undergo biopsy do not have prostate cancer, yet suffer the pain    and side effects of the procedure.  <\/p><p>    It is estimated that successful    implementation of the EV-FPS test could eventually eliminate up    to 600,000 unnecessary biopsies, 24,000 hospitalisations and up    to 50 per cent of unnecessary treatments for prostate cancer each year in North America alone, Lewis    said.  <\/p><p>    \"Compared to elevated total PSA alone,    the EV-FPS test can more accurately predict the result of    prostate biopsy in previously unscreened men,\" added Adrian    Fairey, Urologist from the University of Alberta.  <\/p><p>    --IANS  <\/p><p>    karthik\/rt\/nir\/bg  <\/p><p>    (This story has not been edited by    Business Standard staff and is auto-generated from a syndicated    feed.)  <\/p><p>      Using nanotechnology,      scientists have developed a new diagnostic process that can      identify aggressive prostate cancer      from a single drop of blood with 40 per cent more accuracy      than current screening methods.    <\/p><p>      The Extracellular Vesicle      Fingerprint Predictive Score (EV-FPS) test uses machine      learning to combine information from millions of cancer cell nano-particles in the blood to      recognise the unique fingerprint of aggressive prostate      cancer.    <\/p><p>      The diagnostic, evaluated in a      group of men suspected of prostate cancer, correctly      identified aggressive prostate cancer      40 per cent more accurately than the most common blood test      -- Prostate-Specific Antigen (PSA) and helped them avoid      unnecessary painful biopsies and over-treatment.    <\/p><p>      \"Higher sensitivity means that      our test will miss fewer aggressive cancers...for this kind      of test you want the sensitivity to be as high as possible      because you don't want to miss a single cancer that should be treated,\" said John Lewis      from the University of Alberta in Canada.    <\/p><p>      Current tests such as the PSA      and digital rectal exam (DRE) often lead to unneeded      biopsies, the researchers said, while presenting the paper at      the International Society for Extracellular Vesicles      conference in Toronto recently.    <\/p><p>      More than 50 per cent of men      who undergo biopsy do not have prostate cancer, yet suffer      the pain and side effects of the procedure.    <\/p><p>      It is estimated that successful      implementation of the EV-FPS test could eventually eliminate      up to 600,000 unnecessary biopsies, 24,000 hospitalisations      and up to 50 per cent of unnecessary treatments for prostate      cancer each year in North America alone,      Lewis said.    <\/p><p>      \"Compared to elevated total PSA      alone, the EV-FPS test can more accurately predict the result      of prostate biopsy in previously unscreened men,\" added      Adrian Fairey, Urologist from the University of      Alberta.    <\/p><p>      --IANS    <\/p><p>      karthik\/rt\/nir\/bg    <\/p><p>      (This story has not been edited      by Business Standard staff and is auto-generated from a      syndicated feed.)    <\/p><p>      IANS    <\/p><p>        <a href=\"http:\/\/bsmedia.business-standard.com\/_media\/bs\/wap\/images\/bs_logo_amp.png\" rel=\"nofollow\">http:\/\/bsmedia.business-standard.com\/_media\/bs\/wap\/images\/bs_logo_amp.png<\/a>        177 22      <\/p><p><!-- Auto Generated --><\/p><p><img decoding=\"async\" src=\"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-content\/uploads\/2017\/06\/c99da07de2go_amp.png-150x19.png\" style=\"padding-left:10px; padding-right: 10px;\"><\/p><p>Link: <\/p><p><a target=\"_blank\" rel=\"nofollow\" href=\"http:\/\/www.business-standard.com\/article\/news-ians\/nanotech-based-test-can-predict-prostate-cancer-risk-better-117061000410_1.html\" title=\"Nanotech-based test can predict prostate cancer risk better ... - Business Standard\">Nanotech-based test can predict prostate cancer risk better ... - Business Standard<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p> IANS | Toronto June 10, 2017 Last Updated at 15:42 IST Using nanotechnology, scientists have developed a new diagnostic process that can identify aggressive prostate cancer from a single drop of blood with 40 per cent more accuracy than current screening methods. The Extracellular Vesicle Fingerprint Predictive Score (EV-FPS) test uses machine learning to combine information from millions of cancer cell nano-particles in the blood to recognise the unique fingerprint of aggressive prostate cancer.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanotech\/nanotech-based-test-can-predict-prostate-cancer-risk-better-business-standard.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[431610],"tags":[],"class_list":["post-218447","post","type-post","status-publish","format-standard","hentry","category-nanotech"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/218447"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=218447"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/218447\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=218447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=218447"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=218447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}